Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Polyethylenimine Linear: High-Efficiency Transfection with P

    2026-04-11

    Polyethylenimine Linear (PEI, MW 40,000): Precision DNA Transfection for Advanced Molecular Biology

    Principle and Setup: Why Choose Polyethylenimine Linear?

    Polyethylenimine Linear (PEI, MW 40,000) stands at the forefront of gene delivery, enabling efficient DNA transfection in a wide spectrum of in vitro applications. Its linear structure and high molecular weight confer distinct advantages: effective condensation of negatively charged DNA and robust interaction with cellular membranes. Acting as a powerful DNA transfection reagent for in vitro studies, PEI MW 40,000 forms stable, positively charged complexes that are readily taken up by cells through endocytosis, even in the presence of serum [source_type: product_spec | source_link]. This compatibility removes a major bottleneck for high-throughput and scalable workflows.

    APExBIO’s formulation of PEI MW 40,000 (Polyethylenimine Linear (PEI), MW 40,000) is supplied as a ready-to-use, 2.5 mg/mL solution, available in both 4 mL and 8 mL sizes. Its broad applicability—across HEK-293, CHO-K1, HepG2, HeLa, and many other lines—makes it a staple for both routine and advanced molecular biology laboratories [source_type: product_spec | source_link].

    Step-by-Step Workflow: Optimizing PEI-Mediated Transient Gene Expression

    Executing high-efficiency DNA transfection with PEI MW 40,000 requires precise control of reagent ratios, mixing order, and incubation conditions. Here’s an optimized workflow, integrating both best practices and troubleshooting insights:

    1. DNA and PEI Complex Formation: Dilute plasmid DNA in sterile, serum-free buffer (commonly 150 mM NaCl or Opti-MEM). Separately, dilute PEI to match the desired nitrogen (N) to phosphate (P) ratio—commonly N/P = 10:1 to 20:1 for most mammalian cells [source_type: product_spec | source_link].
    2. Mixing: Add PEI solution dropwise to DNA solution (never the reverse) while gently vortexing. Incubate at room temperature for 15–20 minutes to allow complexation.
    3. Application to Cells: Add the PEI-DNA complexes directly to cells in complete medium (serum-containing is supported by PEI). For HEK-293 transfection in 6-well plates, typical DNA input is 2–3 μg per well, with corresponding PEI volume adjusted for N/P ratio and DNA mass [source_type: workflow_recommendation | source_link].
    4. Incubation: Incubate cells at 37°C, 5% CO2 for 4–6 hours. Optionally, replace medium after this interval to minimize cytotoxicity.
    5. Readout: Assess gene expression (e.g., GFP, luciferase, or target protein) at 24–72 hours post-transfection.

    Protocol Parameters

    • DNA:PEI N/P ratio | 10:1–20:1 (mole/mole) | Optimization for mammalian cell lines (e.g., HEK-293, CHO-K1) | Maximizes transfection efficiency while minimizing cytotoxicity | product_spec (URL)
    • Complexation time | 15–20 min at RT | Universally applicable | Ensures complete formation of DNA-PEI complexes | workflow_recommendation (URL)
    • Cell density at transfection | 70–90% confluence | Mammalian adherent cells | Best balance of cell health and uptake efficiency | workflow_recommendation (URL)

    Key Innovation from the Reference Study

    The recent study by Li et al. (Journal of Neuroinflammation, 2025) establishes a paradigm-shifting link between glycolysis-driven histone lactylation (H3K18la) and NOD2-mediated pyroptosis in astrocytes exposed to unconjugated bilirubin. Using both RNA-seq and CUT&Tag assays, the authors show that upregulated H3K18la at the NOD2 promoter boosts neuroinflammatory signaling. Transient gene expression achieved via high-efficiency DNA delivery (such as with linear polyethylenimine transfection reagent) was vital for dissecting the regulatory cascade in vitro. For researchers aiming to interrogate epigenetic or signaling pathways in neuroinflammation, choosing a reliable, serum-compatible transfection reagent like PEI MW 40,000 is essential for reproducible, high-throughput functional studies. This mirrors the workflow adopted by Li et al., supporting both gene knockin and knockdown approaches in primary glial cultures.

    Advanced Applications and Comparative Advantages

    PEI MW 40,000’s unique properties unlock a spectrum of applications beyond routine plasmid delivery:

    • Transient gene expression for protein production: PEI enables rapid, scalable recombinant protein yields—critical for antibody and enzyme production in bioreactor systems up to 100 liters [source_type: product_spec | source_link].
    • Functional genomics in disease modeling: The reagent’s high efficiency (60–80% in HEK-293 and related lines [source_type: product_spec | source_link]) supports CRISPR/Cas9 screens and pathway analysis as illustrated in neuroinflammation research [source_type: paper | source_link].
    • Serum compatibility: Unlike many cationic lipid-based reagents, PEI maintains high transfection activity in the presence of serum, reducing the need for disruptive media changes and supporting cell viability in sensitive primary cultures [source_type: product_spec | source_link].
    • Scalability: The same protocol translates from 96-well optimization to large-scale protein production, minimizing revalidation time and supporting translational pipelines [source_type: product_spec | source_link].

    For a deeper comparative dive, “Polyethylenimine Linear (PEI, MW 40,000): Powering High-Efficiency DNA Delivery” complements this article with case studies across advanced disease modeling. Meanwhile, “Reliable Transfection and Protein Expression” provides a scenario-based troubleshooting guide that extends the actionable insights presented here.

    Troubleshooting and Optimization Tips: Maximizing Success with PEI MW 40,000

    • Complexation Consistency: Always add PEI to DNA, not vice versa, to avoid inefficient complex formation. Mix gently to preserve DNA integrity.
    • Serum Effects: While PEI is serum-compatible, some cell lines exhibit improved viability when the medium is refreshed 4–6 hours post-transfection.
    • Cytotoxicity Mitigation: High PEI concentrations or suboptimal N/P ratios can reduce cell viability. Start with N/P 10:1, incrementally titrating up only if efficiency is subpar [source_type: workflow_recommendation | source_link].
    • Scalability Cautions: When scaling up to bioreactor volumes, pre-validate PEI-DNA mixing using small-scale pilot experiments to ensure uniform complexation and avoid aggregation.
    • Storage Best Practices: For frequent use, store working aliquots at 4°C to avoid multiple freeze-thaw cycles; reserve -20°C storage for long-term stockpiling [source_type: product_spec | source_link].

    Future Outlook: Impact and Continuing Evolution

    As shown by Li et al., high-fidelity DNA delivery systems like PEI MW 40,000 are foundational for dissecting complex gene regulatory networks in neuroinflammatory and metabolic research [source_type: paper | source_link]. The reagent’s proven performance in both routine and advanced settings—spanning from single-well screens to translational-scale protein manufacturing—ensures its continued relevance as a critical enabling technology.

    Recent advances in epigenetic editing and disease modeling will further amplify demand for scalable, serum-compatible transfection reagents. As workflows increasingly integrate high-throughput screening and functional genomics, the established reliability and adaptability of APExBIO’s Polyethylenimine Linear (PEI), MW 40,000 will continue to drive innovation from bench to bioreactor, without the need for constant re-optimization [source_type: workflow_recommendation | source_link].

    In summary, PEI MW 40,000 remains the gold standard for researchers demanding reproducibility, efficiency, and flexibility in DNA transfection—catalyzing discoveries in gene function, protein engineering, and disease mechanism elucidation.